Mylan commences offer to acquire Perrigo
14 September 2015 | By Victoria White
Under the terms of the offer, Perrigo shareholders will receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share...
List view / Grid view
News
Resveratrol stabilises Alzheimer’s disease biomarker
14 September 2015 | By Victoria White
Patients who were treated with increasing doses of resveratrol over 12 months showed little or no change in amyloid-beta40 (Abeta40) levels...
Ustekinumab gets UK launch for adolescents with psoriasis
14 September 2015 | By Victoria White
A clinical study demonstratement that ustekinumab can improve psoriasis symptoms and lessen its impact on quality of life in young people aged 12 and over...
Positive top-line results in second LixiLan Phase III study
14 September 2015 | By Victoria White
The fixed-ratio combination of insulin glargine and lixisenatide, a GLP-1 receptor agonist, demonstrated statistically superior reduction in HbA1c compared with insulin glargine alone...
FDA approves Humira for hidradenitis suppurativa
The US Food and Drug Administration (FDA) has approved AbbVie’s Humira (adalimumab) for the treatment of moderate to severe hidradenitis suppurativa.
FDA approves Abbreviated NDAs for Mucinex equivalent products
11 September 2015 | By Victoria White
Allergan has said that its partner, Perrigo, will begin shipments of the products to its retail and wholesale customers in the US in time for the 2016 cough and cold season...
Biogen licenses MT-1303 from Mitsubishi Tanabe Pharma
11 September 2015 | By Victoria White
Biogen is assessing the potential of MT-1303 in multiple sclerosis (MS), ulcerative colitis, Crohn’s disease, and other autoimmune indications...
AstraZeneca purchases US biologics manufacturing facility
11 September 2015 | By Victoria White
The facility will eventually double AstraZeneca’s biologics manufacturing capacity in the US to meet the needs of the Company’s maturing pipeline...
Study reports high sustained viral response with Viekirax + Exviera in GT1 HCV
11 September 2015 | By Victoria White
Interim results from the independent AMBER study demonstrated a 98% SVR12 rate in patients who completed a 12- or 24-week treatment regimen...
IBEF reports a surge in the Indian pharmaceutical sector
10 September 2015 | By Victoria White
The Indian domestic pharma market is estimated to reach US$ 15 billion by the end of the 2015 financial year, says India Brand Equity Foundation (IBEF)...
EC approves label update for BMS’ Daklinza
10 September 2015 | By Victoria White
The update allows the use of Daklinza in combination with sofosbuvir for 12 weeks in patients without cirrhosis in all 28 Member States of the European Union...
Thermo Fisher Scientific receives IVDD CE Mark
Thermo Fisher Scientific, the world leader in serving science, announced that it received the in vitro diagnostics device (IVDD) CE mark for its Thermo Scientific Prelude MD HPLC, Endura MD mass spectrometer and ClinQuan MD software.
Wanted: clever minds!
10 September 2015 | By Shimadzu
‘lab4you’ program for young scientists / Laboratory space available for research / Brief abstract for application...
Janssen submits MAA for daratumumab to EMA
10 September 2015 | By Victoria White
Daratumumab is an investigational, human anti-CD38 monoclonal antibody, for the treatment of patients with relapsed and refractory multiple myeloma...
FDA grants Priority Review to ixazomib for multiple myeloma
10 September 2015 | By Victoria White
Ixazomib is the first investigational oral proteasome inhibitor for the treatment of patients with relapsed and/or refractory multiple myeloma...
